Researchers are getting closer to understanding how germ cells in the embryo acquire pluripotency-the ability to generate all cells of the body, aside from those of the placenta. A new study outlines the role of two key factors in this process-the transcription factor Blimp-1 (also known as Prdm-1, PR domain zinc finger protein 1) and the protein kinase Akt [1] .
Primordial germ cells (PGCs), which are specified during day seven of embryonic development in the mouse, are not pluripotent-for instance, they do not give rise to any cell lineages when injected into blastocysts, a common assay. Pluripotency is acquired as embryogenesis proceeds, as PGCs become pluripotent embryonic germ cells (EGCs). Go Nagamatsu, Toshio Suda, and their colleagues studied the PGC-to-EGC transition to understand the acquisition of pluripotency. The researchers examined this transition using PGCs isolated from mouse embryos. They then converted the PGCs to EGCs in cell cultures containing various signaling regulators.
Previous studies have implicated both Blimp-1 and Akt in inducing EGC cell fate. To examine the influence of these two factors more closely, the researchers deployed whole-transcriptome analysis to analyze the PGC-to-EGC transition in wild-type cells, as well as cells with various factors missing or activated, including Blimp-1 and Akt. Further work in embryonic stem cells supplemented this effort.
The researchers concluded that Blimp-1 acts as a ''pluripotency gatekeeper'' protein in PGCs. Deleting Blimp-1 in PGCs accelerated the transition to pluripotency, and overexpressing Blimp-1 in embryonic stem cells suppressed the expression of genes known to be involved in pluripotency. The researchers also concluded that Akt promotes the acquisition of pluripotency. For instance, Akt synergized with other factors in culture to accelerate the PGC-to-EGC transition.
These findings have implications for protocols attempting to generate germ cells in culture-currently researchers can readily generate PGCs from embryonic stem cells or from induced pluripotent stem cells, but the production of sperm or oocytes is an elusive goal. The findings also provide insight into the reprogramming of somatic cells into a pluripotent state-for instance, in the current study, Akt was found to suppress genes regulated by MBD3 (methyl-CpG binding domain protein 3), a factor implicated in somatic cell reprogramming.
